Antibiotic resistance threats in the United States, 2019
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
This report is dedicated to the 48,700 families who lose a loved one each year to antibiotic resistance or Clostridioides difficile, and the countless healthcare providers, public health experts, innovators, and others who are fighting back with everything they have.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Non-albicans Candida species tend to be more resistant to antifungal drugs than C albicans, and the emergence of drug-resistance among both albicans and non-albicans Candida, including C auris, constitutes a major public health threat [7].”
From Treatment practices for adults with candidemia at 9 active surveillance sites—United States, 2017–2018. (2021) · cites this paper as [7]
Citations
Cites
Performance standards for antimicrobial susceptibility testing
Ferraro, M. J. (2001) · Cited by 9,667
A Modified Poisson Regression Approach to Prospective Studies with Binary Data
Zou, G. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh090 · Cited by 9,615
Foodborne illness acquired in the United States—Major pathogens
Scallan, E., Hoekstra, R. M., Angulo, F. J., Tauxe, R. V., Widdowson, M.-A., Roy, S. L., Jones, J. L., & Griffin, P. M. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1701.p11101 · Cited by 7,657
Performance standards for antimicrobial susceptibility testing
Weinstein, M. P., & Clinical (2019) · Clinical and Laboratory Standards Institute eBooks · Cited by 4,341
Robust Inference With Multiway Clustering
Cameron, A. C., Gelbach, J. B., & Miller, D. L. (2011) · Journal of Business & Economic Statistics · doi:10.1198/jbes.2010.07136 · Cited by 3,203
Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011
Fleming-Dutra, K. E., Hersh, A. L., Shapiro, D. J., Bartoces, M., Enns, E. A., File, T. M., Finkelstein, J. A., Gerber, J. S., Hyun, D. Y., Linder, J. A., et al. (2016) · JAMA · doi:10.1001/jama.2016.4151 · Cited by 1,740
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Control of Communicable Diseases Manual
(2015) · American Public Health Association eBooks · doi:10.2105/ccdm.2745 · Cited by 1,599
Simple formulas for standard errors that cluster by both firm and time
Thompson, S. B. (2011) · Journal of Financial Economics · doi:10.1016/j.jfineco.2010.08.016 · Cited by 1,512
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,425
Dedrick, R. M., Guerrero-Bustamante, C. A., Garlena, R. A., Russell, D. A., Ford, K., Harris, K., Gilmour, K. C., Soothill, J., Jacobs-Sera, D., Schooley, R. T., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0437-z · Cited by 1,410
Challenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
VANCOMYCIN-RESISTANT ENTEROCOCCI
Uttley, A. C., Collins, C. H., Naidoo, J., & George, R. C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91037-9 · Cited by 1,226
Knothe, H., Shah, P., Krcmery, V., Antal, M., & Mitsuhashi, S. (1983) · Infection · doi:10.1007/bf01641355 · Cited by 912
Global Trends in Typhoid and Paratyphoid Fever
Crump, J. A., & Mintz, E. D. (2010) · Clinical Infectious Diseases · doi:10.1086/649541 · Cited by 888
Association of adverse events with antibiotic use in hospitalized patients.
Tamma, P. D., Avdic, E., Li, D. X., Dzintars, K., & Cosgrove, S. E. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.1938 · Cited by 800
Review of statistical methods for analysing healthcare resources and costs
Mihaylova, B., Briggs, A., O'Hagan, A., & Thompson, S. G. (2011) · Health Economics · doi:10.1002/hec.1653 · Cited by 767
Greenland, S. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh221 · Cited by 727
Kourtis, A. P., Hatfield, K., Baggs, J., Mu, Y., See, I., Epson, E., Nadle, J., Kainer, M. A., Dumyati, G., Petit, S., et al. (2019) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6809e1 · Cited by 701
Reported tuberculosis in the United States 2013
Aids, V. H., & Prevetion, T. (2014) · Medical Entomology and Zoology · Cited by 608
Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2018
Kreisel, K. M., Spicknall, I. H., Gargano, J. W., Lewis, F. M. T., Lewis, R. M., Markowitz, L. E., Roberts, H., Johnson, A. S., Song, R., St. Cyr, S. B., et al. (2021) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001355 · Cited by 530
The Relative Merits of Risk Ratios and Odds Ratios
Cummings, P. (2009) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2009.31 · Cited by 501
Hansman, D., & Bullen, M. M. (1967) · The Lancet · doi:10.1016/s0140-6736(67)92346-x · Cited by 499
Cooper, M. A., & Shlaes, D. (2011) · Nature · doi:10.1038/472032a · Cited by 474
Summers, W. C. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.437 · Cited by 474
Owusu-Edusei, K., Chesson, H. W., Gift, T. L., Tao, G., Mahajan, R., Ocfemia, M. C. B., & Kent, C. K. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318285c6d2 · Cited by 452
Robust Inference with Multi-way Clustering
Cameron, A. C., Gelbach, J., & Miller, D. (2006) · National Bureau of Economic Research · doi:10.3386/t0327 · Cited by 409
STAPHYLOCOCCUS AUREUS RESISTANT TO VANCOMYCIN???UNITED STATES, 2002
&NA; (2002) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-200203000-00016 · Cited by 395
Sexually Transmitted Diseases Surveillance
Unav (2009) · Harvard Dataverse · doi:10.7910/dvn/rl11z5 · Cited by 317
Healthcare utilization and cost of pneumococcal disease in the United States
Huang, S. S., Johnson, K. M., Ray, G. T., Wroe, P., Lieu, T. A., Moore, M. R., Zell, E. R., Linder, J. A., Grijalva, C. G., Metlay, J. P., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.02.088 · Cited by 296
Chow, N. A., Gade, L., Tsay, S. V., Forsberg, K., Greenko, J. A., Southwick, K. L., Barrett, P. M., Kerins, J. L., Lockhart, S. R., Chiller, T. M., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30597-8 · Cited by 289
First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate
Humphries, R. M., Yang, S., Hemarajata, P., Ward, K. W., Hindler, J. A., Miller, S. A., & Gregson, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01165-15 · Cited by 255
(2007) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2007.06.012 · Cited by 253
Francois Watkins, L. K., McGee, L., Schrag, S. J., Beall, B., Jain, J. H., Pondo, T., Farley, M. M., Harrison, L. H., Zansky, S. M., Baumbach, J., et al. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.7269 · Cited by 210
The economic burden of Clostridium difficile
McGlone, S. M., Bailey, R. R., Zimmer, S. M., Popovich, M. J., Tian, Y., Ufberg, P., Muder, R. R., & Lee, B. Y. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03571.x · Cited by 206
The Morbidity, Mortality, and Costs Associated with Clostridium difficile Infection
Kwon, J. H., Olsen, M. A., & Dubberke, E. R. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2014.11.003 · Cited by 178
Parameter Estimation and Goodness-of-Fit in Log Binomial Regression
Blizzard, L., & Hosmer, W. (2006) · Biometrical Journal · doi:10.1002/bimj.200410165 · Cited by 160
Attributable Outcomes of EndemicClostridium difficile–associated Disease in Nonsurgical Patients
Dubberke, E. R., Butler, A. M., Reske, K. A., Agniel, D. M., Olsen, M. A. A., D’Angelo, G., McDonald, L. C., & Fraser, V. J. (2008) · Emerging infectious diseases · doi:10.3201/eid1407.070867 · Cited by 156
FLUCONAZOLE RESISTANCE IN CANDIDA GLABRATA
Warnock, D. W., Burke, J., Cope, N. J., Johnson, E. M., Fraunhofer, N. A. V., & Williams, E. W. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92919-4 · Cited by 146
Chochua, S., Metcalf, B. J., Li, Z., Rivers, J., Mathis, S., Jackson, D. M., Gertz, R. E., Srinivasan, V., Lynfield, R., Beneden, C. V., et al. (2017) · mBio · doi:10.1128/mbio.01422-17 · Cited by 142
A comparison of a multistate inpatient EHR database to the HCUP Nationwide Inpatient Sample
DeShazo, J. P., & Hoffman, M. A. (2015) · BMC Health Services Research · doi:10.1186/s12913-015-1025-7 · Cited by 126
A Laboratory-Based, Hospital-Wide, Electronic Marker for Nosocomial Infection
Brossette, S. E., Hacek, D. M., Gavin, P. J., Kamdar, M. A., Brossette, S. E., Fisher, A. G., & Peterson, L. R. (2005) · American Journal of Clinical Pathology · doi:10.1309/502aupr8ve67mbde · Cited by 108
McCann, E., Srinivasan, A., DeRyke, C. A., Ye, G., DePestel, D. D., Murray, J., & Gupta, V. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy241 · Cited by 106
US Emergency Department Visits for Adverse Drug Events From Antibiotics in Children, 2011–2015
Lovegrove, M. C., Geller, A. I., Fleming-Dutra, K. E., Shehab, N., Sapiano, M. R. P., & Budnitz, D. S. (2018) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piy066 · Cited by 102
Jones, J., Weiss, K., Mermin, J., Dietz, P., Rosenberg, E. S., Gift, T. L., Chesson, H., Sullivan, P. S., Lyles, C., Bernstein, K. T., et al. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000980 · Cited by 94
Brossette, S. E., Hacek, D. M., Gavin, P. J., et al. (2006) · PubMed · Cited by 85
Vancomycin-resistant enterococci
Uttley, A. H. C., Woodford, N., Johnson, A. P., Cookson, B., George, R. C., Wilcox, M., Spencer, R. C., Weeks, G., Frieden, T. R., Munsiff, S. S., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)91440-w · Cited by 85
Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010–2011
Fleming-Dutra, K. E., Hersh, A. L., Shapiro, D. J., Bartoces, M. G., Enns, E. A., File, T. M., Finkelstein, J. A., Gerber, J. S., Hyun, D. Y., Linder, J. A., et al. (2016) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000364 · Cited by 79
Phage therapy’s latest makeover
Schmidt, C. W. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0133-z · Cited by 78
Carbapenem-Nonsusceptible Acinetobacter baumannii , 8 US Metropolitan Areas, 2012–2015
Bulens, S. N., Yi, S. H., Walters, M. S., Jacob, J. T., Bower, C. W., Reno, J., Wilson, L. E., Vaeth, E., Bamberg, W., Janelle, S. J., et al. (2018) · Emerging infectious diseases · doi:10.3201/eid2404.171461 · Cited by 77
Geller, A. I., Lovegrove, M. C., Shehab, N., Hicks, L. A., Sapiano, M. R. P., & Budnitz, D. S. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4430-x · Cited by 69
"Celbenin"-resistant Staphylococci
Stewart, G. T. (1960) · BMJ · doi:10.1136/bmj.2.5205.1085-a · Cited by 65
Stewart, D. B., & Hollenbeak, C. S. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1615-6 · Cited by 56
Soge, O. O., Harger, D., Schafer, S., Toevs, K., Raisler, K., Venator, K., Holmes, K. K., & Kirkcaldy, R. D. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3182685d2b · Cited by 51
Saïdani, N., Lagier, J., Cassir, N., Million, M., Baron, S. A., Dubourg, G., Eldin, C., Kerbaj, J., Valles, C., Raoult, D., et al. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.11.014 · Cited by 49
Chesson, H. W., Kirkcaldy, R. D., Gift, T. L., Owusu‐Edusei, K., & Weinstock, H. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000725 · Cited by 37
Ridgway, J. P., Sun, X., Tabak, Y. P., Johannes, R. S., & Robicsek, A. A. (2016) · American Journal of Infection Control · doi:10.1016/j.ajic.2015.12.044 · Cited by 32
Guh, A. Y., Mu, Y., Baggs, J. M., Winston, L. G., Bamberg, W., Lyons, C., Farley, M. M., Wilson, L. E., Holzbauer, S., Phipps, E. C., et al. (2018) · American Journal of Infection Control · doi:10.1016/j.ajic.2017.11.026 · Cited by 31
Matsumura, J. S., Stroupe, K. T., Lederle, F. A., Kyriakides, T. C., Ge, L., Freischlag, J. A., Ketteler, E. R., Kingsley, D. D., Marek, J. M., Massen, R. J., et al. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.08.003 · Cited by 19
Reno, J., Schenck, C., Scott, J., Clark, L. A., Wang, Y. F., Ray, S. M., Vagnone, P. S., & Jacob, J. T. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/675608 · Cited by 12
Keegan, K. D. (2008) · Wiley eBooks · doi:10.1002/9781118673508.ch3 · Cited by 11
Attributable Cost and Length of Stay Associated with Nosocomial Gram-Negative Bacterial Cultures
Nelson, R. E., Stevens, V. W., Jones, M., Khader, K., Schweizer, M. L., Perencevich, E. N., Rubin, M. A., & Samore, M. H. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00462-18 · Cited by 9
Leuck, A., Ahmad, A., & Dunny, G. M. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw172.1596 · Cited by 3
Cited by
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02724-0 · Cited by 16,316
Antimicrobial resistance: a global multifaceted phenomenon
Prestinaci, F., Pezzotti, P., & Pantosti, A. (2015) · Pathogens and Global Health · doi:10.1179/2047773215y.0000000030 · Cited by 3,296
CARD 2020: Antibiotic Resistome Surveillance with the Comprehensive Antibiotic Resistance Database
Alcock, B. P., Raphenya, A. R., Lau, T. T. Y., Tsang, K. K., Bouchard, M., Edalatmand, A., Huynh, W., Nguyen, A.-L. V., Cheng, A. A., Liu, S., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz935 · Cited by 3,202
Alcock, B. P., Huynh, W., Chalil, R., Smith, K. W., Raphenya, A. R., Wlodarski, M. A., Edalatmand, A., Petkau, A., Syed, S. A., Tsang, K. K., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac920 · Cited by 2,441
Antimicrobial Resistance: Implications and Costs
Dadgostar, P. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s234610 · Cited by 2,024
Metadata
- Authors
- (U.S.), C. F. D. C. A. P.
- Published
- 2019-11
- OpenAlex
- W4242318543
- Semantic Scholar
- 8631606aa4656ea63c340051d5b9951406177b5c
- Cited by
- 5,782
- References
- 64
- Citations by year
- 2026: 118 · 2025: 350 · 2024: 593 · 2023: 689 · 2022: 728 · 2021: 766 · 2020: 705 · 2019: 408
- Type
- report
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- Locations
- HAL (submittedVersion, other-oa)
- Funders
- Centers for Disease Control and Prevention
- National Center for Immunization and Respiratory Diseases
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- antibiotic resistance, Clostridium difficile, antimicrobial use, disease surveillance, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.